| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8246805 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 6 Pages |
Abstract
Conclusion: Administration of growth factors concomitant to radiotherapy might modify the development of kidney dysfunction. Although insulin-like growth factor-1 has previously been shown to protect the kidney, such an effect could not be demonstrated for EPO. The latter agent even increased the development of nephropathy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Nicolaus M.D., Andrea Schnaitera, Wolfgang A. M.D., Lu Caia, Sabine M.Sc., Nicole M.D., Markus M.D., Michael M.D., Carsten M.D.,